MA22915A1 - Methodes de traitement de l'osteoporose pour utilisation de faibles doses de phosphonates. - Google Patents

Methodes de traitement de l'osteoporose pour utilisation de faibles doses de phosphonates.

Info

Publication number: MA22915A1
Authority: MA; Morocco
Prior art keywords: high potency; day; thirty; phosphonates; potency phosphonate
Prior art date: 1992-06-30

Application number

MA23219A

Other languages

English (en)

Inventor

Waite Boyce Rogely

David Francis Marion

Original Assignee

Procter & Gamble Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-30

Filing date

1993-06-29

Publication date

1993-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25422708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA22915(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-06-29 Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma

1993-12-31 Publication of MA22915A1 publication Critical patent/MA22915A1/fr

Links

208000001132 Osteoporosis Diseases 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
-1 phosphonate compound Chemical class 0.000 abstract 4
241000124008 Mammalia Species 0.000 abstract 1
210000000988 bone and bone Anatomy 0.000 abstract 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 abstract 1
238000007910 systemic administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA23219A 1992-06-30 1993-06-29 Methodes de traitement de l'osteoporose pour utilisation de faibles doses de phosphonates. MA22915A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US90660992A	1992-06-30	1992-06-30

Publications (1)

Publication Number	Publication Date
MA22915A1 true MA22915A1 (fr)	1993-12-31

Family

ID=25422708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA23219A MA22915A1 (fr)	1992-06-30	1993-06-29	Methodes de traitement de l'osteoporose pour utilisation de faibles doses de phosphonates.

Country Status (13)

Country	Link
EP (1)	EP0648120B1 (fr)
JP (2)	JP4481368B2 (fr)
KR (1)	KR950702120A (fr)
AT (1)	ATE161423T1 (fr)
AU (1)	AU659329B2 (fr)
CA (1)	CA2138367C (fr)
DE (1)	DE69316013T2 (fr)
DK (1)	DK0648120T3 (fr)
ES (1)	ES2111163T3 (fr)
GR (1)	GR3025792T3 (fr)
HU (1)	HUT70210A (fr)
MA (1)	MA22915A1 (fr)
WO (1)	WO1994000129A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2727629A1 (fr) *	1994-12-06	1996-06-07	Sanofi Sa	Trousse pour cycle de traitement de l'osteoporose
AU701258B2 (en) *	1994-12-28	1999-01-21	Gador S.A.	Bone mass anabolic composition comprising olpadronate
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
AU2005227418B2 (en) *	1997-07-22	2008-05-29	Merck Sharp & Dohme Corp.	Method for inhibiting bone resorption
US6432932B1 (en)	1997-07-22	2002-08-13	Merck & Co., Inc.	Method for inhibiting bone resorption
DE69803291T2 (de) *	1997-07-22	2002-08-08	Merck & Co Inc	Methoden zur verhinderung von knochenresorption
AU2007211965B2 (en) *	1997-07-22	2008-05-15	Merck Sharp & Dohme Corp.	Alendronate for use in the treatment of osteoporosis
US5994329A (en) *	1997-07-22	1999-11-30	Merck & Co., Inc.	Method for inhibiting bone resorption
AR013994A1 (es) *	1998-10-30	2001-01-31	Gador Sa	Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
WO2000028982A2 (fr) *	1998-11-19	2000-05-25	The Board Of Trustees For The University Of Arkansas	Renforcement de la structure osseuse a l'aide de diphosphonates selectionnes
DK1296689T3 (da)	2000-06-20	2005-11-28	Novartis Ag	Fremgangsmåde til indgivelse af bisphosphonater
BR0308901A (pt)	2002-05-10	2005-01-04	Hoffmann La Roche	ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose
EP2001486A4 (fr) *	2006-03-17	2010-12-29	Univ Illinois	Composés de biphosphonates et procédés
ITPA20070034A1 (it) *	2007-10-30	2009-04-30	Tetrapharm S R L	Bifosfonati geminali, loro preparazione e loro impiego in campo oncologico.
US8882740B2 (en)	2009-12-23	2014-11-11	Stryker Trauma Gmbh	Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
TWI730039B (zh) *	2016-01-29	2021-06-11	日商富士藥品股份有限公司	新穎雙膦酸化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL77243A (en) *	1984-12-21	1996-11-14	Procter & Gamble	Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
PH27078A (en) *	1984-12-21	1993-02-01	Procter & Gamble	Pharmaceutical compositions containing geminal diphosphonates
US4761406A (en) *	1985-06-06	1988-08-02	The Procter & Gamble Company	Regimen for treating osteoporosis
IL84731A0 (en) *	1986-12-19	1988-05-31	Norwich Eaton Pharma	Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
IL86951A (en) *	1987-07-06	1996-07-23	Procter & Gamble Pharma	Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
DE4011777A1 (de) *	1989-04-14	1990-10-18	Ciba Geigy Ag	N-trisubstituierte aminoalkandiphosphonsaeuren

1993
- 1993-06-04 ES ES93914339T patent/ES2111163T3/es not_active Expired - Lifetime
- 1993-06-04 EP EP93914339A patent/EP0648120B1/fr not_active Revoked
- 1993-06-04 AU AU44038/93A patent/AU659329B2/en not_active Ceased
- 1993-06-04 DK DK93914339.2T patent/DK0648120T3/da active
- 1993-06-04 WO PCT/US1993/005267 patent/WO1994000129A1/fr not_active Ceased
- 1993-06-04 DE DE69316013T patent/DE69316013T2/de not_active Revoked
- 1993-06-04 CA CA002138367A patent/CA2138367C/fr not_active Expired - Fee Related
- 1993-06-04 AT AT93914339T patent/ATE161423T1/de not_active IP Right Cessation
- 1993-06-04 JP JP50236694A patent/JP4481368B2/ja not_active Expired - Lifetime
- 1993-06-04 HU HU9403762A patent/HUT70210A/hu unknown
- 1993-06-29 MA MA23219A patent/MA22915A1/fr unknown
1994
- 1994-12-30 KR KR1019940704866A patent/KR950702120A/ko not_active Abandoned
1997
- 1997-12-30 GR GR970403268T patent/GR3025792T3/el unknown
2010
- 2010-01-15 JP JP2010006922A patent/JP2010106042A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
HUT70210A (en)	1995-09-28
WO1994000129A1 (fr)	1994-01-06
DE69316013D1 (de)	1998-02-05
AU4403893A (en)	1994-01-24
JP2010106042A (ja)	2010-05-13
ATE161423T1 (de)	1998-01-15
JPH07508278A (ja)	1995-09-14
EP0648120B1 (fr)	1997-12-29
AU659329B2 (en)	1995-05-11
CA2138367A1 (fr)	1994-01-06
KR950702120A (ko)	1995-06-19
CA2138367C (fr)	1998-09-22
DE69316013T2 (de)	1998-07-09
EP0648120A1 (fr)	1995-04-19
JP4481368B2 (ja)	2010-06-16
DK0648120T3 (da)	1998-01-19
ES2111163T3 (es)	1998-03-01
GR3025792T3 (en)	1998-03-31

Publication	Publication Date	Title
KR950702120A (ko)	1995-06-19	골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
KR950702121A (ko)	1995-06-19	포스포네이트 및 비스테로이드계 소염 약물(nasid)을 함유하는 관절염 치료 조성물(compositions for the treatment of arthritis containing phosphonates and nsaids)
ATE189400T1 (de)	2000-02-15	Knochenwachstumsfördernde zusammensetzung
SE8504967D0 (sv)	1985-10-22	A pharmaceutical composition and a method of treating the body
RU94046316A (ru)	1996-10-20	Применение высокоэффективных фосфонатов при изготовлении лекарственных средств для лечения остеопороза
ATE105482T1 (de)	1994-05-15	Behandlung von krebs mit somatostatin und mit analogen davon.
CA2075904A1 (fr)	1991-08-10	Methode de traitement du syndrome pre-menstruel
DK0573604T3 (da)	1995-05-29	Fremgangsmåde til behandling af osteoporosis
BE898749A (fr)	1984-05-16	Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
EP0482089A4 (en)	1993-02-17	Methods of treating or preventing autoimmune uveoretinitis in mammals
DK0862454T3 (da)	2002-12-30	CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
EP0093497A3 (fr)	1985-03-20	Traitement anthelminthique
FI952018A0 (fi)	1995-04-27	BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
NO962503L (no)	1996-06-13	Anvendelse av penoksyfyllin ved behandling av multippel sklerose
AU1621888A (en)	1988-11-04	Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
FR2657005B1 (fr)	1992-05-29	Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
NO945058L (no)	1995-02-28	Anvendelse av fosfonater for behandling av osteoporose
RU96100080A (ru)	1998-03-27	Лечение состояний, связанных с нарушением уровня паратгормона
JPS5758630A (en)	1982-04-08	Interferon inducer
ATE74767T1 (de)	1992-05-15	Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.